Abstract
The term Wnt was forged by contraction of Win gless-type mouse mammary tumour virus int egration site after the discovery on a viral oncogene in mice which was homologous to a mutant Drosophila gene. The Wnt pathway, especially under its canonical form (Wnt–β-catenin pathway), is a signalling pathway involved in vertebrate and invertebrate development. It plays a major role in embryogenesis and morphogenesis and in stem cell commitment to differentiation or proliferation. This pathway is relatively complex, and all its processes and physiological roles are not completely deciphered. The proteins involved in this pathway are called ‘Wingless’, ‘Frizzled’, ‘Dishevelled’, which originally designated the mutants of Drosophila development and demonstrates the universality of this pathway in the animal kingdom. Germline alterations of this pathway in humans determine congenital hereditary diseases, and some somatic and germinal alterations are associated with oncogenesis.
Briefly, protein messengers called WNT activate GPCR-related membrane receptors called Frizzled (FZD), and this activation leads to the stabilisation of the cytoplasmic form of a protein involved in intercellular junctions of epithelial tissues, β-catenin. The stabilised protein can then be transferred into the nucleus where it activates transcription programmes of numerous genes, especially those encoding the proteins required for cell proliferation and cell cycle entry (cyclin D, MYC, etc.).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11–26.
Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 2009;10:468–77.
Arce L, Yokoyama NN, Waterman ML. Diversity of LEF/TCF action in development and disease. Oncogene. 2006;25:7492–504.
Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov. 2006;5:997–1014.
Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149:1192–205.
Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007;19:150–8.
Gavert N, Ben-Ze’ev A. beta-Catenin signaling in biological control and cancer. J Cell Biochem. 2007;102:820–8.
Herr P, Hausmann G, Basler K. WNT secretion and signalling in human disease. Trends Mol Med. 2012;18:483–93.
Huang H, He X. Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol. 2008;20:119–25.
Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene. 2008;27:6920–9.
Katoh M, Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res. 2007;13:4042–5.
Kikuchi A, Yamamoto H. Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling. Cancer Sci. 2008;99:202–8.
Kimelman D, Xu W. beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene. 2006;25:7482–91.
Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387–98.
Mikels AJ, Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene. 2006;25:7461–8.
Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol. 2012;13:767–79.
Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev. 2007;17:45–51.
Takahashi-Yanaga F, Kahn M. Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res. 2010;16:3153–62.
Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97–106.
Wang Y. Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther. 2009;8:2103–9.
Wend P, Holland JD, Ziebold U, Birchmeier W. Wnt signaling in stem and cancer stem cells. Semin Cell Dev Biol. 2010;21:855–63.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Robert, J. (2015). Wnt Pathway. In: Textbook of Cell Signalling in Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-14340-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-14340-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14339-2
Online ISBN: 978-3-319-14340-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)